These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5572144)

  • 1. Unexpected variable in the USP-NF rotating dissolution test.
    Beyer WF; Smith DL
    J Pharm Sci; 1971 Mar; 60(3):496-7. PubMed ID: 5572144
    [No Abstract]   [Full Text] [Related]  

  • 2. Technical problems of the USP-NF dissolution test.
    Mattok GL; McGilveray IJ; Hossie RD
    J Pharm Sci; 1972 Mar; 61(3):460-2. PubMed ID: 5013388
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of BP and USP rotating basket dissolution apparatus.
    Smith WJ; Heaume PE; Hailey DM; Lea AR
    J Pharm Pharmacol; 1985 Feb; 37(2):124-5. PubMed ID: 2858545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation on the USP-NF rotating-basket dissolution apparatus and a new device for dissolution rate studies of solid dosage forms.
    Haringer G; Poulsen BJ; Havemeyer RN
    J Pharm Sci; 1973 Jan; 62(1):130-2. PubMed ID: 4682913
    [No Abstract]   [Full Text] [Related]  

  • 5. USP dissolution III: semilogarithmic dissolution patterns of tablets in rotating-basket assemblies.
    Carstensen JT; Wright JL; Blessel K; Sheridan J
    J Pharm Sci; 1978 Jul; 67(7):982-4. PubMed ID: 660522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic tolbutamide tablet dissolution: intralot and interlot variation.
    Ayres JW; Huang HP; Albert K
    J Pharm Sci; 1984 Nov; 73(11):1629-34. PubMed ID: 6520768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
    Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
    J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lot-to-lot variation in dissolution of tolbutamide tablets.
    Ayres JW
    Am J Hosp Pharm; 1980 Oct; 37(10):1329-32. PubMed ID: 7424928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution test acceptance sampling plans.
    Tsong Y; Hammerstrom T; Lin K; Ong TE
    J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
    Cox DC; Furman WB
    J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
    [No Abstract]   [Full Text] [Related]  

  • 12. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
    Cox DC; Furman WB; Page DP
    J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inferential procedure for the probability of passing the USP dissolution test.
    Chiang C; Chen CF; Huang MY; Liu JP
    Pharm Stat; 2012; 11(1):32-8. PubMed ID: 21506255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dissolution profiles of tablets and capsules from the USP, Levy, and magnetic basket methods.
    Needham TE; Luzzi LA
    J Pharm Sci; 1974 Jun; 63(6):925-8. PubMed ID: 4851107
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-stage sequential statistical dissolution testing rules.
    Tsong Y; Shen M; Shah VP
    J Biopharm Stat; 2004 Aug; 14(3):757-79. PubMed ID: 15468763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution.
    Cammarn SR; Sakr A
    Int J Pharm; 2000 May; 201(2):199-209. PubMed ID: 10878326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of tablet air entrapment using USP 1 rotating-basket dissolution apparatus.
    Sarapu AC; Clark L
    J Pharm Sci; 1980 Jan; 69(1):129. PubMed ID: 7354431
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
    Cox DC; Wells CE; Furman WB; Savage TS; King AC
    J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in dissolution data using an apparatus meeting USP-NF requirements.
    Rosolia AM; O'Connell JR; Bavitz JF; Restaino FA; Schwartz JB
    J Pharm Sci; 1972 Oct; 61(10):1638-40. PubMed ID: 5072416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.